Ocular Therapeutix Inc (NASDAQ:OCUL)

2.95
BATS BZX Real-Time Price
As of 2:22pm ET
 -0.185 / -5.90%
Today’s Change
2.77
Today|||52-Week Range
7.39
-57.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$241.4M

Company Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Contact Information

Ocular Therapeutix, Inc.
24 Crosby Drive
Bedford Massachusetts 01730
P:(781) 357-4000
Investor Relations:

Employees

Shareholders

Other institutional39.97%
Individual stakeholders30.22%
Mutual fund holders15.83%

Top Executives

Antony MattessichPresident, Chief Executive Officer & Director
Donald NotmanChief Financial Officer
Peter JarrettChief Scientific Officer
Rabia Gurses OzdenChief Medical Officer
Karen-Leigh EdwardsSenior Vice President-Technical Operations